Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20260610008Phase 1Completed
Phase 1 trial of caffeine, sponsored by Rangsit University. Primary endpoint: Contrast sensitivity. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20260610008.